- Home
- MACI vs GNLX Comparison
MACI vs GNLX Comparison
Compare MACI & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MACI
- GNLX
- Stock Information
- Founded
- MACI 2024
- GNLX 2001
- Country
- MACI United States
- GNLX United States
- Employees
- MACI N/A
- GNLX N/A
- Industry
- MACI
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- MACI
- GNLX Health Care
- Exchange
- MACI NYSE
- GNLX Nasdaq
- Market Cap
- MACI 221.6M
- GNLX 184.4M
- IPO Year
- MACI 2024
- GNLX 2023
- Fundamental
- Price
- MACI $10.32
- GNLX $2.96
- Analyst Decision
- MACI
- GNLX Strong Buy
- Analyst Count
- MACI 0
- GNLX 4
- Target Price
- MACI N/A
- GNLX $17.75
- AVG Volume (30 Days)
- MACI 9.3K
- GNLX 138.3K
- Earning Date
- MACI 01-01-0001
- GNLX 05-06-2025
- Dividend Yield
- MACI N/A
- GNLX N/A
- EPS Growth
- MACI N/A
- GNLX N/A
- EPS
- MACI N/A
- GNLX N/A
- Revenue
- MACI N/A
- GNLX N/A
- Revenue This Year
- MACI N/A
- GNLX N/A
- Revenue Next Year
- MACI N/A
- GNLX N/A
- P/E Ratio
- MACI $44.17
- GNLX N/A
- Revenue Growth
- MACI N/A
- GNLX N/A
- 52 Week Low
- MACI $9.95
- GNLX $1.60
- 52 Week High
- MACI $10.35
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- MACI N/A
- GNLX 54.28
- Support Level
- MACI N/A
- GNLX $2.26
- Resistance Level
- MACI N/A
- GNLX $3.06
- Average True Range (ATR)
- MACI 0.00
- GNLX 0.31
- MACD
- MACI 0.00
- GNLX 0.04
- Stochastic Oscillator
- MACI 0.00
- GNLX 78.42
About MACI MELAR ACQUISITION CORP. I
Melar Acquisition Corp I is a blank check company.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.